Alembic Pharmaceuticals is set to enter the high-margin US branded market with the launch of “women health antibiotic”, as it looks beyond generics to chart the next phase of growth, managing director ...

https://www.thehindubusinessline.com/news/real-estate/google-parent-gains-exclusive-option-on-more-space-at-bengalurus-alembic-city/article70592100.ece Copy Google ...

Alembic Pharmaceuticals has received tentative approval from the U.S. Food and Drug Administration (U.S. FDA) for its generic of cancer drug Bosutinib Tablets, 400 mg. Bosutinib Tablets, 400 mg, had ...

Alembic Pharmaceuticals Ltd on Monday said it has received tentative approval from the US health regulator for its Bosutinib tablets used in the treatment of certain types of cancer. The tentative ...

BEIJING, Jan 9 (Reuters) - China will cancel value-added tax export rebates for photovoltaic products from April 1, the finance ministry said in a joint statement with the State Taxation ...

Alembic Pharmaceuticals was hit with a patent infringement lawsuit on Dec. 19 in New York Eastern District Court over its planned generic version of the glaucoma treatment LUMIGAN®. The action, ...

Alembic Pharmaceuticals was sued for patent infringement on Dec. 19 in New York Eastern District Court for seeking to market a generic version of glaucoma treatment Lumigan. The action, brought by ...

China plans to implement a steel export licensing mechanism next year, a move that could curb outflow of the metal that has been the subject of trade spats across the globe. The country’s commerce ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic, a startup that offers AI-powered data analytics for marketers, said it has raised $145 million in a fundraising round that values the company at $645 million. Alembic’s software is designed ...